Security key
501575104
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR)
CUSIP: 501575104
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 81,496,373
- Total 13F shares
- 89,844,612
- Share change
- +9,115,698
- Total reported value
- $6,991,150,975
- Put/Call ratio
- 198%
- Price per share
- $77.81
- Number of holders
- 253
- Value change
- +$715,972,868
- Number of buys
- 156
- Number of sells
- 79
Report period
Q4 2025
Institutions
253
Top holders
10
KYMR full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Kymera Therapeutics, Inc. SEC filings
Kymera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501575104
Recent filing periods:
Top shareholders of KYMR - Kymera Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
3/4/5
13D/G
13F
|
Director, 10%+ Owner · Company |
11%
from 13D/G
|
18,197,878
mixed-class rows
|
$1,134,150,081 | +$230,183,852 | 11 Dec 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
8.5%
|
6,867,809
|
$436,311,906 | $0 | 11 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
|
T. Rowe Price Associates, Inc. · Company |
7.1%
|
5,097,704
|
$288,530,046 | $0 | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.4%
from 13D/G
|
4,365,448
|
$247,084,359 | — | 30 Sep 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
7.8%
|
6,350,000
|
$359,410,000 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
7.2%
|
5,879,611
|
$332,785,989 | — | 30 Sep 2025 | |
| BVF INC/IL |
13F
|
Company |
6.8%
|
5,502,710
|
$311,453,386 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.7%
|
5,421,722
|
$306,869,465 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.4%
|
5,195,691
|
$294,076,110 | — | 30 Sep 2025 | |
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
6%
|
4,896,462
|
$277,139,749 | — | 30 Sep 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
4.2%
|
3,428,150
|
$194,033,290 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
2,019,454
|
$114,301,096 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,276,766
|
$72,276,364 | — | 30 Sep 2025 | |
| Capital Research Global Investors |
13F
|
Company |
1.5%
|
1,262,182
|
$71,439,501 | — | 30 Sep 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.3%
|
1,027,739
|
$58,170,027 | — | 30 Sep 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
939,094
|
$53,152,720 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.1%
|
863,762
|
$48,888,930 | — | 30 Sep 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
1%
|
840,333
|
$47,562,848 | — | 30 Sep 2025 | |
| Merck & Co., Inc. |
13F
|
Company |
0.95%
|
772,165
|
$43,704,539 | — | 30 Sep 2025 | |
| Commodore Capital LP |
13F
|
Company |
0.92%
|
750,000
|
$42,450,000 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.9%
|
731,420
|
$41,409,153 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.87%
|
711,444
|
$40,267,730 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.8%
|
648,718
|
$36,717,439 | — | 30 Sep 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.79%
|
644,590
|
$36,483,859 | — | 30 Sep 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.75%
|
615,091
|
$34,814,151 | — | 30 Sep 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.75%
|
611,221
|
$34,596,000 | — | 30 Sep 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.7%
|
572,258
|
$32,389,803 | — | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.69%
|
558,700
|
$31,622,420 | — | 30 Sep 2025 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.64%
|
518,057
|
$29,322,026 | — | 30 Sep 2025 | |
| AJU IB Investment Co., Ltd. |
13F
|
Company |
0.56%
|
457,059
|
$25,864,969 | — | 30 Sep 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.55%
|
450,374
|
$25,491,168 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
439,825
|
$24,894,095 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
437,120
|
$24,740,991 | — | 30 Sep 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.53%
|
435,014
|
$24,621,793 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.53%
|
429,975
|
$24,336,585 | — | 30 Sep 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.49%
|
397,041
|
$22,472,521 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
377,799
|
$21,383,456 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.46%
|
372,400
|
$21,077,840 | — | 30 Sep 2025 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.44%
|
360,000
|
$20,376,000 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.44%
|
359,076
|
$20,323,701 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.43%
|
351,246
|
$19,880,524 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.43%
|
346,817
|
$19,782,977 | — | 30 Sep 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
0.42%
|
340,909
|
$19,295,449 | — | 30 Sep 2025 | |
| Deer Management Co. LLC |
13F
|
Company |
0.4%
|
325,895
|
$18,445,657 | — | 30 Sep 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
0.39%
|
319,100
|
$18,061,060 | — | 30 Sep 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.34%
|
277,726
|
$15,719,292 | — | 30 Sep 2025 | |
| BRAIDWELL LP |
13F
|
Company |
0.34%
|
276,692
|
$15,660,767 | — | 30 Sep 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.31%
|
250,000
|
$14,150,000 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.3%
|
248,000
|
$14,036,800 | — | 30 Sep 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.3%
|
246,704
|
$13,963,446 | — | 30 Sep 2025 |
Institutional Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q4 2025
As of 31 Dec 2025,
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) was held by
253 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,844,612 shares.
The largest 10 holders included
FMR LLC, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BVF INC/IL, BlackRock, Inc., Atlas Venture Life Science Advisors, LLC, WELLINGTON MANAGEMENT GROUP LLP, and Siren, L.L.C..
This page lists
253
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
207
Q4 2025 holders
253
Holder diff
46
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.